3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
4
Lung Neoplasms
4
Small Cell Lung Carcinoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Central Nervous System Neoplasms
3
Brain Neoplasms
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Glioma
2
Burkitt Lymphoma
2
Astrocytoma
2
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Pinealoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Nervous System Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Interventions
veliparib
1
sargramostim
1
etoposide phosphate
1
Vincristine
1
Sunitinib
1
Methotrexate
1
Leucovorin
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Nervous System Neoplasms
×
etoposide phosphate
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled